Pooled results showed that the incidence of adverse events were similar between the two groups, including GI discomfort (RR: 1.35, 95% CI: 0.64–2.84, p = 0.43, I2 = 0%; Figure 5(A)), elevated ALT/AST (RR: 1.34, 95% CI: 0.75–2.41, p = 0.33, I2 = 0%; Figure 5(B)), infection (RR: 0.71, 95% CI: 0.38–1.34, p = 0.29, I2 = 0%; Figure 5(C)), elevated glucose (RR: 0.37, 95% CI: 0.06–2.35, p = 0.29, I2 = 0%; Figure 5(D)), and elevated BP (RR: 1.83, 95% CI: 0.33 to 10.04, p = 0.49, I2 = 0%; Figure 5(E)) that require medical treatments. The gene discussed is GPT; the disease is infection.